HANOVER INVESTMENT FUNDS INC
DEFM14A, 1996-02-15
Previous: 21ST CENTURY TRUST SERIES 7, 24F-2NT, 1996-02-15
Next: MUNICIPAL PARTNERS FUND INC, DEF 14A, 1996-02-15



                                  SCHEDULE 14A
                                 (Rule 14a-101)

                    INFORMATION REQUIRED IN PROXY STATEMENT

                           SCHEDULE 14A INFORMATION

          Proxy Statement Pursuant to Section 14(a) of the Securities
                      Exchange Act of 1934 (Amendment No. )

Filed by the Registrant [x in box]

Filed by a Party other than the Registrant [box]

Check the appropriate box:

[box] Preliminary Proxy Statement       [box] Confidential, for Use of the Com-
                                              mission Only (as permitted by
                                              Rule 14a-6(e)(2))


[box] Definitive Proxy Statement

[x in box] Definitive Additional Materials

[box] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12

                       The Hanover Investment Funds, Inc.

- -------------------------------------------------------------------------------
                (Name of Registrant as Specified in Its Charter)

- -------------------------------------------------------------------------------

   (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

   [x in box] $125 per Exchange Act Rules 0-11(c)(l)(ii), 14a-6(i)(l), or
              14a-6(i)(2) or Item 22(a)(2) of Schedule 14A.

   [box] $500 per each party to the controversy pursuant to Exchange Act
         Rule 14a-6(i)(3).

   [box] Fee computed on table below per Exchange Act Rules 14a-6(i)(4)
         and 0-11.

   (l) Title of each class of securities to which transaction applies:

- -------------------------------------------------------------------------------

   (2) Aggregate number of securities to which transaction applies:

- -------------------------------------------------------------------------------

   (3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):

- -------------------------------------------------------------------------------

   (4) Proposed maximum aggregate value of transaction:

- -------------------------------------------------------------------------------

   (5) Total fee paid:

- -------------------------------------------------------------------------------

   [box] Fee paid previously with preliminary materials.

- -------------------------------------------------------------------------------

   [box] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.

   (1) Amount Previously Paid:

- -------------------------------------------------------------------------------

   (2) Form, Schedule or Registration Statement No.:

- -------------------------------------------------------------------------------

   (3) Filing Party:

- -------------------------------------------------------------------------------

   (4) Date Filed:

- -------------------------------------------------------------------------------


<PAGE>

[logo] CHEMICAL


Dear Chemical Bank Savings Incentive Plan Participant

The enclosed material contains important information concerning the proposed
merger of The Hanover Small Capitalization Growth Fund into the Vista Small Cap
Equity Fund. Because you have invested a portion of your contributions in
Fund E of the Chemical Bank Savings Incentive Plan, you are entitled to vote
on the proposed merger. If the merger of these funds is approved, Fund E will
receive shares of the Vista Small Cap Equity Fund, (Institutional Shares) in
exchange for shares of The Hanover Small Capitalization Growth Fund, 
(CBC Benefit Shares). This action is being taken in conjunction with the
merger of Chemical Banking Corporation and The Chase Manhattan Corporation.

Please review the material and return your proxy card in the enclosed envelope
as soon as possible. YOUR VOTE IS VERY IMPORTANT.


Thank You











© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission